~~<i id='F32E2D9017'><strike id='F32E2D9017'><tt id='F32E2D9017'><pre id='F32E2D9017'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

author：fashion 2025-09-28 00:08:02 Page View：624

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dramatic video released of Russian fighter jets 'harassing' US drones over Syria
Next article： Duchenne breakthrough therapy leaves behind pioneering families

knowledge

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Allen Institute goes after foundational questions, CEO Costa says

AllenInstituteCEORuiCostaCourtesyAllenInstituteMappingthebillionsofcellsthatmakeupthebrainisataskmam

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

EU moves toward latest gene techniques in food production to counter climate change, shortages

FILE-EuropeanCommissionerforEuropeanGreenDealFransTimmermansspeaksduringamediaconferenceonthreatsofc

WSS

hotspot

hotspot

leisure time

knowledge

EU moves toward latest gene techniques in food production to counter climate change, shortages